We're committed to providing you with the very best cancer care, and your safety continues to be a top priority. With this in mind, we’ve put in place many new procedures, including a limited visitor policy. This is just one more way of ensuring your safety and that of our staff. Read more
Diagnostic Radiology - NewYork-Presbyterian Hospital/Weill Cornell Medicine
Breast & Oncologic Imaging - Memorial Sloan Kettering Cancer Center
I am a board-certified radiologist with subspecialty expertise in breast and oncologic imaging. I was Chief Resident during my radiology residency, and I subsequently completed a fellowship in breast and body imaging at MSK. I became a member of the MSK faculty in 2019 and am so proud to be practicing among leaders in the field of oncology.
As a member of the Breast Imaging Service, I interpret screening and diagnostic breast imaging studies at the Evelyn H. Lauder Breast Center. These include mammography, contrast-enhanced mammography, digital breast tomosynthesis, breast ultrasound, and breast MRI. I perform image-guided breast interventions, such as stereotactic, ultrasound, and MRI-guided biopsies, as well as preoperative radioactive seed localizations. I also interpret body CT scans, ultrasounds, and radiographs for the Body Imaging Service.
I collaborate with my colleagues in breast surgery, oncology, pathology, and radiation oncology so that as a team we may deliver the best care possible to our patients. Through my clinical practice and research efforts, I am committed to enhancing our understanding of breast cancer and advancing imaging techniques to improve early breast cancer detection and treatment.
I am committed to enhancing our understanding of breast cancer and advancing imaging techniques to improve early breast cancer detection and treatment.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Kristen Coffey discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].